SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-16-016025
Filing Date
2016-08-15
Accepted
2016-08-15 16:15:10
Documents
48
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0616_immudyne.htm 10-Q 560414
2 CERTIFICATION f10q0616ex31i_immudyne.htm EX-31.1 15255
3 CERTIFICATION f10q0616ex32i_immudyne.htm EX-32.1 4622
  Complete submission text file 0001213900-16-016025.txt   2628439

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE immd-20160630.xml EX-101.INS 408489
5 XBRL SCHEMA FILE immd-20160630.xsd EX-101.SCH 27780
6 XBRL CALCULATION FILE immd-20160630_cal.xml EX-101.CAL 22018
7 XBRL DEFINITION FILE immd-20160630_def.xml EX-101.DEF 107252
8 XBRL LABEL FILE immd-20160630_lab.xml EX-101.LAB 263846
9 XBRL PRESENTATION FILE immd-20160630_pre.xml EX-101.PRE 186240
Mailing Address 50 SPRING MEADOW ROAD MT. KISCO NY 10549
Business Address 50 SPRING MEADOW ROAD MT. KISCO NY 10549 (914) 244-1777
Immudyne, Inc. (Filer) CIK: 0000948320 (see all company filings)

IRS No.: 760238453 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-184487 | Film No.: 161832892
SIC: 2833 Medicinal Chemicals & Botanical Products